Recent Advances in Nanotechnology-enabled Biosensors for Detection of Exosomes As New Cancer Liquid Biopsy
Overview
Authors
Affiliations
Cancer liquid biopsy detects circulating biomarkers in body fluids, provides information that complements medical imaging and tissue biopsy, allows sequential monitoring of cancer development, and, therefore, has shown great promise in cancer screening, diagnosis, and prognosis. Exosomes (also known as small extracellular vesicles) are cell-secreted, nanosized vesicles that transport biomolecules such as proteins and RNAs for intercellular communication. Exosomes are actively involved in cancer development and progression and have become promising circulating biomarkers for cancer liquid biopsy. Conventional exosome characterization methods such as quantitative reverse transcription polymerase chain reaction (qRT-PCR) and enzyme-linked immunosorbent assay (ELISA) are limited by low sensitivity, tedious process, large sample volume, and high cost. To overcome these challenges, new biosensors have been developed to offer sensitive, simple, fast, high throughput, low sample consumption, and cost-effective detection of exosomal biomarkers. In this review, we summarized recent advances in nanotechnology-enabled biosensors that detect exosomal RNAs (both microRNAs and mRNAs) and proteins for cancer screening, diagnosis, and prognosis. The biosensors were grouped based on their sensing mechanisms, including fluorescence-based biosensors, colorimetric biosensors, electrical/electrochemical biosensors, plasmonics-based biosensors, surface-enhanced Raman spectroscopy (SERS)-based biosensors, and inductively coupled plasma mass spectrometry (ICP-MS) and photothermal biosensors. The future directions for the development of exosome-based biosensors were discussed.
Liquid Biopsy in the Clinical Management of Cancers.
Ho H, Chung K, Kan C, Wong S Int J Mol Sci. 2024; 25(16).
PMID: 39201281 PMC: 11354853. DOI: 10.3390/ijms25168594.
Potential Immunohistochemical Biomarkers for Grading Oral Dysplasia: A Literature Review.
Zdrojewski J, Nowak M, Nijakowski K, Jankowski J, Scribante A, Gallo S Biomedicines. 2024; 12(3).
PMID: 38540190 PMC: 10967812. DOI: 10.3390/biomedicines12030577.
Exosomes as Powerful Biomarkers in Cancer: Recent Advances in Isolation and Detection Techniques.
Zhang Q, Wang H, Liu Q, Zeng N, Fu G, Qiu Y Int J Nanomedicine. 2024; 19:1923-1949.
PMID: 38435755 PMC: 10906735. DOI: 10.2147/IJN.S453545.
Nanomaterials for Molecular Detection and Analysis of Extracellular Vesicles.
Taylor M, Giacalone A, Amrhein K, Wilson Jr R, Wang Y, Huang X Nanomaterials (Basel). 2023; 13(3).
PMID: 36770486 PMC: 9920192. DOI: 10.3390/nano13030524.
The therapeutic bionanoscience interface.
Melendez J Exp Biol Med (Maywood). 2022; 247(23):2065-2066.
PMID: 36533612 PMC: 9837299. DOI: 10.1177/15353702221144090.